ERBB2 and triple-negative breast carcinoma: The majority of breast cancers, nearly 70%, are hormone receptor-positive (ER+), while the remaining 30% are human epidermal growth factor receptor 2 positive (HER2+) and triple-negative breast cancer (TNBC) [3, 4].